Global epidemiology of heart failure
MS Khan, I Shahid, A Bennis, A Rakisheva… - Nature Reviews …, 2024 - nature.com
Heart failure (HF) is a heterogeneous clinical syndrome marked by substantial morbidity and
mortality. The natural history of HF is well established; however, epidemiological data are …
mortality. The natural history of HF is well established; however, epidemiological data are …
Effects of weight loss in heart failure patients with overweight and obesity: a systematic review and meta-analysis
M Chi, Y Nie, Y Su, N Wang, A Li, T Ma… - European Journal of …, 2023 - academic.oup.com
Aims To perform a systematic review and meta-analysis to evaluate the impact of weight loss
(WL) on the prognosis of overweight and obese patients with heart failure (HF). Methods and …
(WL) on the prognosis of overweight and obese patients with heart failure (HF). Methods and …
Changing health related quality of life and outcomes in heart failure by age, sex and subtype
Background There are calls to integrate serial recordings of health related quality of life
(HRQoL) into routine care, clinical trials and prognosis. Little is known about the relationship …
(HRQoL) into routine care, clinical trials and prognosis. Little is known about the relationship …
[HTML][HTML] Identification of membrane palmitoylated protein 1 (MPP1) as a heart-failure-promoting protein triggered by cardiovascular risk factors and aging
J Abd Alla, E Nerger, A Langer, U Quitterer - Biochemical pharmacology, 2023 - Elsevier
Abstract Membrane-Associated Guanylate Kinase (MAGUK) proteins are scaffold proteins
with well-established functions in the neuronal system. A role of MAGUK protein up …
with well-established functions in the neuronal system. A role of MAGUK protein up …
Prevalence and incidence of heart failure in type 2 diabetes patients: results from a nationwide prospective cohort—the DIABET-IC study
R Gonzalez-Manzanares, M Anguita-Gámez… - Cardiovascular …, 2024 - Springer
Abstract Background Type 2 diabetes (T2D) patients have an increased risk of heart failure
(HF). There are limited data on the association between HF and T2D in specific healthcare …
(HF). There are limited data on the association between HF and T2D in specific healthcare …
Heart Failure Treatment in 2023: Is There a Place for Lipid Lowering Therapy?
H Poloczková, J Krejčí - Current Atherosclerosis Reports, 2023 - Springer
Abstract Purpose of Review An evidence for lipid lowering therapy in heart failure is briefly
summarized in this review. Recent Findings Heart failure therapy is based on recent …
summarized in this review. Recent Findings Heart failure therapy is based on recent …
Spirituality and heart failure: a systematic review
L Cilona, N Veronese, D Lalicata, F Tantillo… - Aging Clinical and …, 2023 - Springer
Objectives Heart failure (HF) is a frequent chronic disease with disturbing symptoms and
complex treatments, associated with depression and lower quality of life. Some studies have …
complex treatments, associated with depression and lower quality of life. Some studies have …
Advances in management of heart failure
P Heidenreich, A Sandhu - bmj, 2024 - bmj.com
Heart failure is increasing in prevalence in many countries with aging populations.
Fortunately, remarkable scientific advances have been made in the past few years that have …
Fortunately, remarkable scientific advances have been made in the past few years that have …
[HTML][HTML] Evaluating biomarkers as tools for early detection and prognosis of heart failure: A comprehensive review
MA Alzaabi, A Abdelsalam, M Alhammadi… - Cardiac Failure …, 2024 - ncbi.nlm.nih.gov
There is a high prevalence of heart failure (HF) worldwide, which has significant
consequences for healthcare costs, patient death and quality of life. Therefore, there has …
consequences for healthcare costs, patient death and quality of life. Therefore, there has …
Head‐to‐head comparison of relevant cell sources of small extracellular vesicles for cardiac repair: Superiority of embryonic stem cells
H González‐King, PG Rodrigues… - Journal of …, 2024 - Wiley Online Library
Small extracellular vesicles (sEV) derived from various cell sources have been
demonstrated to enhance cardiac function in preclinical models of myocardial infarction (MI) …
demonstrated to enhance cardiac function in preclinical models of myocardial infarction (MI) …